Skip to content

Pilot trial on the effect of the consumption of gold kiwifruit on glycaemic control in individuals with prediabetes

Effect of the consumption of gold kiwifruit on glycaemic control in individuals with prediabetes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616000858493
Enrollment
30
Registered
2016-06-30
Start date
2016-07-01
Completion date
2016-08-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is to determine if consumption of two gold kiwifruit per day for 12 weeks favourably alters gut microbiota composition without adversely affecting blood glucose control in people with pre-diabetes..

Interventions

All participants will be asked to consume 2 gold kiwifruit (flesh only) with their breakfast every day for 12 weeks. Adherence will be monitored by food diaries and by measurement of vitamin c in blood samples.

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Prevention
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion criteria: Selection criteria for trial participants will be the requirement to meet the diagnostic criteria for prediabetes according to the American Diabetes Association (ADA) criteria for glycated haemoglobin (HbA1c). All participants will be free living and required to maintain their normal dietary and lifestyle habits for the duration of the trial. ADA criteria for the diagnosis of prediabetes: HbA1c: 39-46 mmol/mol inclusive.

Exclusion criteria

Exclusion criteria: a.Individuals unable to give informed consent. b. Those with an HbA1c outside the range of 39-46 mmol/mol. c. Those with a previous diagnosis of diabetes. d. Those on diabetes medications such as Metformin. e.Those that have taken antibiotics within a month prior to the trial starting. f.Those with a known kiwifruit allergy. g.Those with a medical history of significant gastrointestinal disease for example, coeliac disease, inflammatory bowel disease or a previous bowel resection. h.Women who are pregnant, breastfeeding or planning a pregnancy in the 3 months post selection (trial period) will be excluded. i.Those who have a planned trip overseas in the 3 months post selection will be excluded.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026